NCT02684396View on ClinicalTrials.gov

Phase 1, TAK-648, Single-Rising Dose Study

PHASE1CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

April 30, 2015

Study Completion Date

July 31, 2015

Conditions
Healthy Volunteers
Interventions
DRUG

TAK-648

TAK-648 Solution

DRUG

TAK-648 Placebo

TAK-648 placebo-matching solution

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY